STX6 and cancer: Given the stromal and immunological scores of STX6 in pan-cancer, tumors (THYM, DLBC, LGG, UVM, UCEC, and KIRC) having a strong association between STX6 and immune/stromal scores were chosen to analyze the enrichment score of STX6 in each immune cell type using single-sample gene set enrichment analysis (ssGSEA) [23].